Roche Venture Fund Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 3
Professionals
  • Investments
  • 143
  • Portfolio
  • 34
  • Exits
  • 78
Exits

Roche Venture Fund General Information

Description

Founded in 2002, Roche Venture Fund is the corporate venture capital arm of Roche Holding and is headquartered in Basel, Switzerland. The firm seeks to invest in life science companies in both pharmaceuticals and diagnostics sectors.

Contact Information

Year Founded
2002
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • Grenzacherstrasse 124
  • 4070 Basel
  • Switzerland
+41 061 000 00 00

Roche Venture Fund Investments (143)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Lino Biotech 17-Nov-2020 Seed Round Biotechnology Generating Revenue 0000000 0000000000 00.0
00000000 000000000 25-Sep-2020 00000 00000 000.00 Drug Discovery Generating Revenue
00000000 26-Aug-2020 00000 00000 00000 Biotechnology Clinical Trials - General
0000000 0000000000 15-Aug-2020 00000 00000 Drug Discovery Generating Revenue 0000000 0000000000 00.0
0000000 0000000000 06-Jul-2020 00000 00000 000.00 Drug Discovery Generating Revenue 000000 000000000000 00
000000 28-May-2020 00000 00000 0000 Other Healthcare Services Generating Revenue
0000 000000000000 07-May-2020 00000 00000 000.00 Drug Discovery Startup 0000 0000000000
000000 00000000000 09-Apr-2020 00000 00000 00.00 Drug Discovery Generating Revenue 0000000 0000000000 00.0
Pandion Therapeutics 01-Apr-2020 Early Stage VC 0000 Drug Discovery Generating Revenue/Not Profitable 00000000 0000 00.0
Vaxcyte 26-Mar-2020 Later Stage VC 00000 Drug Discovery Startup
You’re viewing 10 of 143 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Roche Venture Fund Exits (78)

Company Name Exit Date Exit Type Exit Size
Aligos Therapeutics 16-Oct-2020 IPO 00000
00 000000000000 02-Oct-2020 000 00000
0000000 0000000000 17-Jul-2020 000 00000
0000000 12-Jun-2020 000 00000
0000000 00000000 22-May-2020 000000000000000000
000000000 03-Apr-2020 000000000000000000
00000 0000000 0000 29-Jan-2020 000 00000
0000 00000000000 01-Jan-2020 000000000000000000 00000
IDEAYA Biosciences 23-May-2019 IPO 0000
Opsona Therapeutics 13-Jan-2019 Bankruptcy: Liquidation
You’re viewing 10 of 78 exits. Get the full list »

Roche Venture Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Roche Venture Fund Team (12)

Name Title Deals Funds Boards Office
Carole Nuechterlein JD Head 00 0 00 Basel, Switzerland
David Evans Investment Director Basel, Switzerland
Nisha Marathe Ph.D Investment Director 0 0 0 South San Francisc, CA
Gabriella Zöch Project Manager Basel, Switzerland
Monique Schiersing Ph.D Senior Investment Director 0 0 0 Basel, Switzerland
You’re viewing 5 of 12 team members. Get the full list »

Roche Venture Fund Co-Investors (176)

Name With Exits Lead Partner Series Industry
Boxer Capital 5 0 Series chart Industry bar
SR One 0 0 Series chart Industry bar
5AM Ventures 0 0 Series chart Industry bar
RA Capital Management 0 0 Series chart Industry bar
Amgen Ventures 0 0 Series chart Industry bar
You’re viewing 5 of 176 co-investors. Get the full list »